Health Trials

About this trial

The goal of this observational study is to learn about the long-term effects of Dezawa MuseCells to treat various diseases.

The Primary Goal: What is the short-term and long- term outcomes of Dezawa Musecells? Participants treated with Dezawa MuseCells as part of their regular medical care and will answer online survey questions about symptoms and clinical outcomes for 5 years.

Eligibility criteria

Qualifiers

Received Dezawa MuseCells® as Part of Routine Clinical Care

Patients ( and/or authorized representative) capable of providing informed consent and participating in long-term follow-up.

Willingness to Complete Online Survey Assessments

Participants must have reliable access to email or a mobile device and be willing to complete digital surveys at scheduled intervals over a 5-year period.

Disqualifiers

Not Receive Dezawa MuseCells®-Individuals who have not been treated with Dezawa MuseCells® or received a counterfeit/non-licensed product cannot be included.

Unable or Unwilling to Provide Informed Consent Includes individuals with cognitive impairment who lack a legally authorized representative willing to consent on their behalf.

Inability to Participate in Long-Term Digital Follow-Up

Concurrent Participation in an Interventional Clinical Trial Affecting Outcomes

Trial design

Treatments tested in this trial

  • MuseCell Treatment

Treatment groups

5,000 Participants
are divided into 4 treatment groups

Locations

2
Mexico
Regene Labs Guadalajara Mexico
United States
Bioreset Medical33408, North Palm BeachFlorida, United States

Sponsors and collaborators

MuseCell Innovations Pte LTD

Lead sponsor

Source ClinicalTrials.gov